Ocular Therapeutix, Inc (OCUL): Cash & Equivalents
$737.06M
As of 2025-12-31
$598.64M
As of 2026-06-30
+93.1%
3-year compound annual growth
+26.4%
5-year compound annual growth
+37.4%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $737.06M | +88.0% | 2026-02-05, Balance as of period end |
| 2024-12-31 | $392.10M | +100.2% | 2026-02-05, Balance as of period end |
| 2023-12-31 | $195.81M | +91.4% | 2026-02-05, Balance as of period end |
| 2022-12-31 | $102.30M | -37.7% | 2025-03-03, Balance as of period end |
| 2021-12-31 | $164.16M | -28.0% | 2024-03-11, Balance as of period end |
| 2020-12-31 | $228.06M | +318.9% | 2023-03-06, Balance as of period end |
| 2019-12-31 | $54.44M | +0.7% | 2022-02-28, Balance as of period end |
| 2018-12-31 | $54.06M | +30.2% | 2020-03-12, Balance as of period end |
| 2017-12-31 | $41.54M | +26.1% | 2020-03-12, Balance as of period end |
| 2016-12-31 | $32.94M | +7.0% | 2019-03-07, Balance as of period end |
| 2015-12-31 | $30.78M | -17.7% | 2018-03-08, Balance as of period end |
| 2014-12-31 | $37.39M | +113.6% | 2017-03-10, Balance as of period end |
| 2013-12-31 | $17.50M | -26.6% | 2016-03-10, Balance as of period end |
| 2012-12-31 | $23.85M | n/a | 2015-03-20, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Ocular Therapeutix, Inc (OCUL) | 2025-12-31 | $737.06M | +88.0% |
| Q32 Bio Inc. (QTTB) | 2025-12-31 | $48.30M | -38.1% |
| Agios Pharmaceuticals, Inc. (AGIO) | 2025-12-31 | $89.13M | +16.9% |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2025-12-31 | $34.33M | -48.5% |
| Nektar Therapeutics (NKTR) | 2025-12-31 | $15.12M | -65.8% |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | $37.73M | -18.1% |
| Aytu Biopharma, Inc (AYTU) | 2026-06-30 | $26.31M | -15.0% |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | $128.39M | +32.0% |
| Septerna, Inc. (SEPN) | 2025-12-31 | $120.72M | -49.3% |
Compare OCUL, QTTB, AGIO, LXRX side by side · Screen every company in Pharmaceutical Preparations ↗